Symmetry and asymmetry of permeation through toxin-modified Na+ channels.
Single Na+ channels from rat skeletal muscle were inserted into planar lipid bilayers in the presence of either 200 nM batrachotoxin (BTX) or 50 microM veratridine (VT). These toxins, in addition to their ability to shift inactivation of voltage-gated Na+ channels, may be used as probes of ion conduction in these channels. Channels modified by either of the toxins have qualitatively similar selectivity for the alkali cations (Na+ approximately Li+ greater than K+ greater than Rb+ greater than Cs+). Biionic reversal potentials, for example, were concentration independent for all ions studied. Na+/K+ and Na+/Rb+ reversal potentials, however, were dependent on the orientation of the ionic species with respect to the intra- or extracellular face of the channel, whereas Na+/Li+ biionic reversal potentials were not orientation dependent. A simple, four-barrier, three-well, single-ion occupancy model was used to generate current-voltage relationships similar to those observed in symmetrical solutions of Na, K, or Li ions. The barrier profiles for Na and Li ions were symmetric, whereas that for K ions was asymmetric. This suggests the barrier to ion permeation for K ions may be different than that for Na and Li ions. With this model, these hypothetical energy barrier profiles could predict the orientation-dependent reversal potentials observed for Na+/K+ and Na+/Rb+. The energy barrier profiles, however, were not capable of describing biionic Na/Li ion permeation. Together these results support the hypothesis that Na ions have a different rate determining step for ion permeation than that of K and Rb ions.
Garber
S S
SS
Department of Biochemistry, Brandeis University, Waltham, Massachusetts 02254.
D000818:Animals; D001496:Batrachotoxins / Q000494:pharmacology*; D002414:Cations, Monovalent; D002463:Cell Membrane Permeability; D004553:Electric Conductivity; D008051:Lipid Bilayers; D008564:Membrane Potentials / Q000187:drug effects; D009132:Muscles / Q000502:physiology; D051381:Rats; D015222:Sodium Channels / Q000187:drug effects / Q000502:physiology*; D014701:Veratridine / Q000494:pharmacology*; D014702:Veratrine / Q000031:analogs & derivatives*
D001496:Batrachotoxins; D002414:Cations, Monovalent; D008051:Lipid Bilayers; D015222:Sodium Channels; D014701:Veratridine; D014702:Veratrine